Page 22 - Astrazeneca

AstraZeneca's Covid-19 vaccine to begin clinical trials in China this year

AstraZeneca plans to start early and mid-stage clinical trials of its Covid-19 vaccine candidate in China this year, a senior executive said, as it prepares a global rollout of the vaccine

AstraZeneca beats Q3 sales estimate on strong demand; backs 2020 outlook

Product sales, which exclude payments from collaborations, rose 7 per cent to $6.52 billion for the three months ended September 30 on a constant-currency basis

Bharat Biotech's coronavirus vaccine may be launched in February

Moderna and AstraZeneca are close behind the largest US drugmaker and are likely to have early data on their vaccine candidates before the end of the year.

AstraZeneca to bring non-US vaccine data before FDA for emergency approval

If and when AstraZeneca reaches the first statistically reliable efficacy and safety results from those trials, based on more than 25,000 volunteers in total, it would present them to the US Food and

AstraZeneca Pharma India Q2 net profit up 83% at Rs 26.33 crore

Drug firm AstraZeneca Pharma India on Thursday reported an 83.48 per cent rise in its net profit at Rs 26.33 crore for the quarter ended September 2020. The company had posted a net profit of Rs 14.41 crore for the corresponding period of the previous fiscal, it said in a filing to the BSE. Revenue from operations stood at Rs 209.47 crore for the quarter under consideration. It was Rs 208.48 crore for the same period a year ago, it added. Shares of AstraZeneca Pharma India closed at Rs4,295.80per scrip on the BSE, up 0.40 per cent from their previous close.

Britain prepares for Covid-19 vaccine as Oxford forecasts result this year

There are more than 200 candidates under development and the vaccine being developed by Oxford and licensed to British drugmaker AstraZeneca is seen as a front-runner

UK starts accelerated review for AstraZeneca's potential Covid-19 vaccine

"We confirm the MHRA's (Medicines and Healthcare Products Regulatory Agency) rolling review of our potential Covid-19 vaccine," an AstraZeneca spokesman said

UK starts real-time review of Moderna's Covid-19 vaccine candidate

Moderna said earlier this month it was going to apply for real-time reviews of its experimental Covid-19 vaccine to Europe, following rolling reviews of shots of its rivals Pfizer Inc and AstraZeneca

Oxford Covid-19 vaccine prompts immune response among adults: AstraZeneca

The Financial Times reported that the vaccine, being developed by Oxford and AstraZeneca, triggers protective antibodies and T-cells in older age groups. It cited two people familiar with the finding

Johnson & Johnson, AstraZeneca to resume trial for Covid-19 vaccine

Earlier, AstraZeneca said it had been cleared by the FDA to restart a trial that had been halted in the U.S. after a volunteer participating in a U.K. trial of the shot had fallen ill

AstraZeneca resumes US Covid vaccine trial; J&J prepares for same next week

(Reuters) - AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.

AstraZeneca resumes US Covid-19 vaccine trial, optimism seen for J&J

AstraZeneca's US trial was paused on September 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial

AstraZeneca's volunteer who died didn't get Covid-19 vaccine: Report

Brazil's health authority Anvisa said it had been informed on Monday of the study volunteer's death and had received a partial report from an international committee assessing the trial's safety

AstraZeneca Covid-19 vaccine trial volunteer dies, did not receive dose

Oxford confirmed the plan to keep testing

World Coronavirus Dispatch: China finds infection risk in frozen food packs

Brazil's weekly cases lowest in 5 months, New Zealand has first community case in three weeks, Israel eases curbs and other pandemic-related news across the globe

Race for coronavirus cure hits reality as clinic complications mount

Regulators and drugmakers have faced questions about whether political pressure was overwhelming scientific rigor ahead of the presidential election on Nov. 3

AstraZeneca's Covid-19 antibody drug heads into final testing stage

The drug will be evaluated for its ability to prevent infections for up to a year in some people and as a preemptive medicine once patients have been exposed to the virus in others

Inhaled vaccines aim to target coronavirus at its point of invasion

Most vaccines in human testing require two shots for effectiveness, and developers still aren't even sure if they'll prevent infections

US, AstraZeneca strike deal for Covid-19 antibody treatment touted by Trump

The US government has awarded $486 mn to AstraZeneca Plc to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment

AstraZeneca could profit from Covid-19 vaccine as early as July: Report

AstraZeneca could start profiting from its Covid-19 vaccine as soon as July next year, the Financial Times reported